Delivery Order SPE2DB20D2104-SPE2DB23FU09D

Award Date 6/22/23
Potential Completion Date 6/23/23
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,711.69, is for the supply of HUMIRA(CF) 40 MG/0.4 ML SYRINGES. This order is part of Amerisourcebergen's $999,999,999 IDC with the DLA, which serves as a primary vehicle for providing a comprehensive range...
This is a $9,236.08 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA 40 MG/0.8 ML syringes. The order has an ultimate completion date of August 28, 2024 and is a firm fixed-price contract. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to deliver a wide range of medical commodities...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,979.90 firm fixed-price contract is for the supply of HUMIRA(CF)40MG/.4ML 2S medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which covers a comprehensive range of medical...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,037.10 contract is for providing HUMIRA 40 MG/0.8 ML syringes, a specialty medication used for various inflammatory conditions. The IDC with the DLA Troop Support Medical, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $14,085.76 firm-fixed-price contract is for the delivery of HUMIRA 40 mg/0.8 ml syringes, a specialty pharmaceutical product. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,894.24 delivery order is for the supply of HUMIRA 40 MG/0.8 ML SYRINGES, a specialty medication. This order is part of a larger IDC potentially valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of medical commodities,...
This firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of HUMIRA 40 MG/0.8 ML syringes. The $2,446.34 contract has a completion date of June 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for military...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,770.74 contract is for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA 40 MG/0.8 ML SYRINGES. The $3,326.76 firm fixed-price contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,887.42 firm fixed-price delivery order is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FU09D
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,697.76 firm fixed-price contract is for the delivery of HUMIRA 40 MG/0.8 ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between Amerisourcebergen and the DLA, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 1:37 PM